The DOI matches its Crossref record; 643 of the 656 references it cites were found in a registry or an index.
Neuroendocrine pharmacology of stress
Abstract
Exposure to hostile conditions initiates responses organized to enhance the probability of survival. These coordinated responses, known as stress responses, are composed of alterations in behavior, autonomic function and the secretion of multiple hormones. The activation of the renin-angiotensin system and the hypothalamic-pituitary-adrenocortical axis plays a pivotal role in the stress response. Neuroendocrine components activated by stressors include the increased secretion of epinephrine and norepinephrine from the sympathetic nervous system and adrenal medulla, the release of corticotropin-releasing factor (CRF) and vasopressin from parvicellular neurons into the portal circulation, and seconds later, the secretion of pituitary adrenocorticotropin (ACTH), leading to secretion of glucocorticoids by the adrenal gland. Corticotropin-releasing factor coordinates the endocrine, autonomic, behavioral and immune responses to stress and also acts as a neurotransmitter or neuromodulator in the amygdala, dorsal raphe nucleus, hippocampus and locus coeruleus, to integrate brain multi-system responses to stress. This review discussed the role of classical mediators of the stress response, such as corticotropin-releasing factor, vasopressin, serotonin (5-hydroxytryptamine or 5-HT) and catecholamines. Also discussed are the roles of other neuropeptides/neuromodulators involved in the stress response that have previously received little attention, such as substance P, vasoactive intestinal polypeptide, neuropeptide Y and cholecystokinin. Anxiolytic drugs of the benzodiazepine class and other drugs that affect catecholamine, GABA(A), histamine and serotonin receptors have been used to attenuate the neuroendocrine response to stressors. The neuroendocrine information for these drugs is still incomplete; however, they are a new class of potential antidepressant and anxiolytic drugs that offer new therapeutic approaches to treating anxiety disorders. The studies described in this review suggest that multiple brain mechanisms are responsible for the regulation of each hormone and that not all hormones are regulated by the same neural circuits. In particular, the renin-angiotensin system seems to be regulated by different brain mechanisms than the hypothalamic-pituitary-adrenal system. This could be an important survival mechanism to ensure that dysfunction of one neurotransmitter system will not endanger the appropriate secretion of hormones during exposure to adverse conditions. The measurement of several hormones to examine the mechanisms underlying the stress response and the effects of drugs and lesions on these responses can provide insight into the nature and location of brain circuits and neurotransmitter receptors involved in anxiety and stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When the brain receives stress input, multiple pathways containing the autonomic nervous system and hypothalamic-pituitary-adrenal axis (HPA axis) are activated (20).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [20]
Citations
Cites
Items 401–600 of 643
Laaris, N., Poul, E. L., Hamon, M., & Lanfumey, L. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00187.x · Cited by 61
(1996) · PubMed · Cited by 61
Molecular Forms of Cholecystokinin in the Brain and the Relationship to Neuronal Gastrinsa
Rehfeld, J. F., Hansen, H. F., Marley, P. D., & Stengaard‐Pedersen, K. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb29902.x · Cited by 60
Nisenbaum, L. K., & Abercrombie, E. D. (1993) · Brain Research · doi:10.1016/0006-8993(93)91469-9 · Cited by 60
Immunoelectronmicroscopic localization of vasopressin in the rat suprachiasmatic nucleus
van Leeuwen, F. W., Swaab, D. F., & de Raay, C. (1978) · Cell and Tissue Research · doi:10.1007/bf00221596 · Cited by 60
Funada, M., & Hara, C. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02160-6 · Cited by 60
GRK3 mediates desensitization of CRF1receptors: a potential mechanism regulating stress adaptation
Dautzenberg, F. M., Braun, S. L., & Hauger, R. L. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.4.r935 · Cited by 60
Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
Aguilera, G., & Rabadan‐Diehl, C. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00004.x · Cited by 59
Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated
Żukowska-Grójec, Z., Shen, G. H., Capraro, P. A., & Vaz, C. A. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90317-h · Cited by 59
Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo
Mantyh, P. W., Rogers, S. D., Ghilardi, J. R., Maggio, J. E., Mantyh, C. R., & Vigna, S. R. (1996) · Brain Research · doi:10.1016/0006-8993(96)00050-9 · Cited by 59
Nussdorfer, G. G., Bahçelioğlu, M., Neri, G., & Malendowicz, L. K. (2000) · Peptides · doi:10.1016/s0196-9781(99)00193-x · Cited by 59
Stress-induced disruption of parturition in the rat may be mediated by endogenous opioids
Leng, G., Mansfield, S., Bicknell, R. J., Brown, D., Chapman, C., Hollingsworth, S., Ingram, C. D., Marsh, M., Yates, J. O., & Dyer, R. G. (1987) · Journal of Endocrinology · doi:10.1677/joe.0.1140247 · Cited by 58
Role of neuropeptide Y (NPY) in cardiovascular responses to stress
Zukowska‐Grojec, Z., & Vaz, A. (1988) · Synapse · doi:10.1002/syn.890020319 · Cited by 58
The role of CRF receptor subtypes in stress-induced behavioural responses
Smagin, G. N., & Dunn, A. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00553-7 · Cited by 58
Splanchnic vasoconstriction in heat-stressed men: role of renin-angiotensin system
Escourrou, P., Freund, P. R., Rowell, L. B., & Johnson, D. G. (1982) · Journal of Applied Physiology · doi:10.1152/jappl.1982.52.6.1438 · Cited by 58
Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT
Remy, S. M., Schreiber, R., Dalmus, M., & Vry, J. D. (1996) · Psychopharmacology · doi:10.1007/bf02247397 · Cited by 57
Maciag, C. M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00398-0 · Cited by 57
Muscle fibre type and dimension in genetically obese and lean Zucker rats
HE, D., Bolstad, G., Brubakk, A. O., & Medbø, J. I. (1995) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1995.tb09938.x · Cited by 57
Larsen, P., Mikkelsen, J. D., Jessop, D., Lightman, S. L., & Chowdrey, H. S. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01138.1993 · Cited by 57
To, C., & Bagdy, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00176-2 · Cited by 56
Rudehill, A., OLCÉN, M., Sollevi, A., Hamberger, B., & LUNDBER, J. M. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08271.x · Cited by 56
Lundberg, J. M., Pernow, J., Fried, G. M., & Änggård, A. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08198.x · Cited by 56
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat
Heilig, M. A., & Murison, R. C. C. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90191-9 · Cited by 56
A comparison of acute stress paradigms: Hormonal responses and hypothalamic serotonin
PARIS, J., Lorens, S. A., Vandekar, L., URBAN, J., Morton, K. D. R., & Bethea, C. L. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90341-6 · Cited by 56
Self-citationEvidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors.
Rittenhouse, P. A., Bakkum, E. A., Levy, A. D., Li, Q., Carnes, M. L., & de Kar, L. D. V. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24053-8 · Cited by 55
Bannon, M. J., Deutch, A. Y., Tam, S., Zamir, N., Eskay, R. L., Lee, J., Maggio, J. E., & Roth, R. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)90097-1 · Cited by 55
PITUITARY-ADRENAL ACTIVATION IN RATS WITH HEREDITARY HYPOTHALAMIC DIABETES INSIPIDUS
Arimura, A., Saito, T., Bowers, C. Y., & Schally, A. V. (1967) · European Journal of Endocrinology · doi:10.1530/acta.0.0540155 · Cited by 55
Paulmyer‐Lacroix, O., Héry, M., PUGEAT, M. M., & Grino, M. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.04835.x · Cited by 55
Wong, M., WEBSTER, E. L., Spokes, H., Phu, P., Ehrhart‐Bornstein, M., Bornstein, S. R., Park, C. S., Rice, K. C., Chrousos, G. P., Licinio, J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00268-4 · Cited by 54
Multiple affinity states of different cholecystokinin receptors
Huang, S., Fortune, K. P., Wank, S. A., Kopin, A. S., & Gardner, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47167-0 · Cited by 54
Central Action of Adrenal Steroids During Stress and Adaptation
Reul, J. M. H. M., Sutanto, W., van Eekelen, J. A. M., Rothuizen, J. J., & de Kloet, E. R. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_15 · Cited by 53
Curtis, G. C., Abelson, J. L., & Gold, P. W. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00578-1 · Cited by 53
Kling, M. A., Geracioti, T. D., Licinio, J., Michelson, D., Oldfield, E. H., & Gold, P. W. (1994) · PubMed · Cited by 53
Gibson, A., Hart, S. L., & Patel, S. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90248-0 · Cited by 52
Sim‐Selley, L. J., Vogt, L. J., Xiao, R., Childers, S. R., & Selley, D. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00875-4 · Cited by 52
Regulation of the Stress Response by Corticotropin-Releasing Factor Receptors
Hauger, R. L., & Dautzenberg, F. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-707-9_15 · Cited by 52
Singh, V. B., Onaivi, E. S., Phan, T.-H., & Boadle‐Biber, M. C. (1990) · Brain Research · doi:10.1016/0006-8993(90)90656-v · Cited by 51
Adrenal cortical responses to vasoactive intestinal peptide in conscious hypophysectomized calves.
Bloom, S. R., Edwards, A. V., & Jones, C. T. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016748 · Cited by 51
Kaji, H., Chihara, K., Abe, H., Kita, T., KASHIO, Y., Okimura, Y., & Fujita, T. (1985) · Endocrinology · doi:10.1210/endo-117-5-1914 · Cited by 50
Rohrer, T. R., von Richthofen, V., Schulz, C., Beyer, J., & Lehnert, H. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1000811 · Cited by 50
Chowdreyxa, H. S., Larsen, P. J., Harbuz, M. S., Lightman, S. L., & Jessop, D. S. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02194-n · Cited by 50
Neuroendocrinology of Stress: Implications for Growth and Development
Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (2008) · Hormone Research · doi:10.1159/000184269 · Cited by 50
Steroids, Stability and Stress
de Kloet, E. R. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1015 · Cited by 49
Shapira, B., Newman, M. E., Gelfin, Y., & Lerer, B. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00067-0 · Cited by 49
CSF corticotropin-releasing factor is not affected in panic disorder
Jolkkonen, J., Lepola, U., Bissette, G., Nemeroff, C., & Riekkinen, P. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90315-5 · Cited by 49
Dickstein, G., DEBOLD, C. R., Gaitan, D., DeCherney, G. S., Jackson, R. V., Sheldon, W. R., Nicholson, W. E., & Orth, D. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768855 · Cited by 49
Saphier, D., Farrar, G. E., & Welch, J. E. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00056-g · Cited by 48
Morton, K. D. R., de Kar, L. D. V., Brownfield, M. S., Lorens, S. A., Napier, C., & Urban, J. H. (2008) · Neuroendocrinology · doi:10.1159/000125356 · Cited by 48
Pommier, B., Nascimento, S. D., Dumont, S., Bellier, B., Million, E., Garbay, C., Roques, B. P., & Noble, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730281.x · Cited by 48
Corticotropin-releasing factor binding sites in cortex of depressed suicides
Hucks, D., Lowther, S., Crompton, M. R., Katona, C., & Horton, R. W. (1997) · Psychopharmacology · doi:10.1007/s002130050439 · Cited by 48
Cassens, G., Kuruc, A., Roffman, M., Orsulak, P. J., & Schildkraut, J. J. (1981) · Behavioural Brain Research · doi:10.1016/0166-4328(81)90020-6 · Cited by 48
Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.
Inui, A., Okita, M., Nakajima, M., Momose, K., Ueno, N., Teranishi, A., Miura, M., Hirosue, Y., Sano, K., Sato, M., et al. (1998) · PubMed · Cited by 48
Neurobiological investigations into the role of cholecystokinin in panic disorder.
Bradwejn, J. (1993) · PubMed Central · Cited by 47
Hensler, J. G., & Durgam, H. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703855 · Cited by 47
Vasopressin gene is expressed at low levels in the hypothalamus of the Brattleboro rat.
Majzoub, J. A., Pappey, A., Burg, R., & Habener, J. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5296 · Cited by 47
Naloxone-Induced Dissociation of Oxytocin and Prolactin Releases
Samson, W. K., McDonald, J. K., & Lumpkin, M. D. (2008) · Neuroendocrinology · doi:10.1159/000124053 · Cited by 47
Kondo, H., Kuramoto, H., & Fujita, T. (1986) · Cell and Tissue Research · doi:10.1007/bf00218554 · Cited by 47
Raap, D. K., García, F., Muma, N. A., Wolf, W. A., Battaglia, G., & de Kar, L. D. V. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37990-x · Cited by 46
Co‐release of neuropeptide Y (NPY)‐like immunoreactivity and catecholamines in newborn infants
Lundberg, J. M., Hemsén, A., Fried, G. M., THEODORSSON‐NORHEIM, E., & Lagercrantz, H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07842.x · Cited by 46
Adrenocorticotropin,β-Endorphin, and Corticosterone Secretion in Brattleboro Rats*
Conte‐Devolx, B., Giraud, P., Oliver, C., Castanas, E., Boudouresque, F., Gillioz, P., & MILLET, Y. (1982) · Endocrinology · doi:10.1210/endo-110-6-2097 · Cited by 46
Vasopressin Receptor Mutations and Nephrogenic Diabetes Insipidus
Birnbaumer, M. (1999) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00063-6 · Cited by 46
Grino, M., Paulmyer‐Lacroix, O., Faudon, M., Renard, M., & Anglade, G. (1994) · Endocrinology · doi:10.1210/endo.135.6.7988443 · Cited by 45
Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro
Faria, M. D. S., Navarra, P., Tsagarakis, S., BESSER, G. M., & Grossman, A. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90378-9 · Cited by 44
Stress elicits trans-synaptic activation of adrenal neuropeptide Y gene expression
Hiremagalur, B., Květňanský, R., Nankova, B. B., Fleischer, J., Geertman, R. T., Fukuhara, K., Viskupic, E., & Sabban, E. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90194-5 · Cited by 44
Leboulenger, F., Leroux, P., Tonon, M., Coy, D. H., Vaudry, H., & Pelletier, G. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90434-2 · Cited by 44
Nicot, A. B., Rowe, W. B., de Kloet, E. R., Betancur, C., Jessop, D. S., Lightman, S. L., Quirion, R., Rostène, W. H., & Bérod, A. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.00581.x · Cited by 43
Levenson, C. W., & Moore, J. B. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00064-0 · Cited by 43
Nuclear localization of the human mutY homologue hMYH
Tsai-Wu, J.-J., Su, H., Wu, Y., Hsu, S.-M., & Wu, C. H. H. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000615)77:4 · Cited by 42
Kaji, H., Chihara, K., Kita, T., KASHIO, Y., Okimura, Y., & Fujita, T. (2008) · Neuroendocrinology · doi:10.1159/000124231 · Cited by 42
Vasoactive intestinal peptide (VIP) stimulates aldosterone secretion by rat adrenal glands in vivo
Nussdorfer, G. G., & Mazzocchi, G. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90072-0 · Cited by 42
Ferrini, M. G., & Nicola, A. F. D. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90617-k · Cited by 41
Role of serotonin in the amygdala in hypothalamo-pituitaryadrenocortical responses
Feldman, S., Newman, M. E., Gur, E., & Weidenfeld, J. (1998) · Neuroreport · doi:10.1097/00001756-199806220-00017 · Cited by 41
Biosynthesis of Vasopressin and Oxytocin
Brownstein, M. J. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.001021 · Cited by 41
Hezareh, M., Schlegel, W., & Rawlings, S. R. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.04645.x · Cited by 40
Lundberg, J. M., Rudehill, A., & Sollevi, A. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90401-9 · Cited by 40
Altemus, M. M., Smith, M. A., Diep, V., Aulakh, C. S., & Murphy, D. L. (1994) · Anxiety · doi:10.1002/anxi.3070010602 · Cited by 39
WATABE, T., TANAKA, K., KUMAGAE, M., ITOH, S., KOGURE, M., HASEGAWA, M., HORIUCHI, T., MORIO, K., TAKEDA, F., UBUKATA, E., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1132 · Cited by 39
Buckingham, J. C., & Cooper, T. A. (2008) · Neuroendocrinology · doi:10.1159/000124820 · Cited by 38
Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice
Groenink, L., van der Gugten, J., Zethof, T. J. J., der Heyden, J. A. M. V., & Olivier, B. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02177-9 · Cited by 38
Role of Neuropeptide Y in Cold Stress-Induced Hypertension
Han, S., Chen, X., Cox, B. F., Yang, C.-L., Wu, Y., Naes, L., & Westfall, T. C. (1998) · Peptides · doi:10.1016/s0196-9781(97)00297-0 · Cited by 38
Distribution of immunoreactive cholecystokinin in the human hippocampus
Lotstra, F., & Vanderhaeghen, J. (1987) · Peptides · doi:10.1016/0196-9781(87)90080-5 · Cited by 38
The role of the adrenal gland in cytoprotection against stress‐induced gastric ulcers in rats
Hernández, D. E., Adcock, J. W., Nemeroff, C. B., & Prange, A. J. (1984) · Journal of Neuroscience Research · doi:10.1002/jnr.490110209 · Cited by 38
Kjær, A., Knigge, U., Olsen, L. O., Vilhardt, H., & Warberg, J. (1991) · Endocrinology · doi:10.1210/endo-128-1-103 · Cited by 38
Berlin, I., Warot, D., Legout, V., Guillemant, S., Schöllnhammer, G., & Puech, A. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90038-8 · Cited by 37
Effect of insulin on brain 5-hydroxytryptamine and 5-hydroxy-indole-acetic acid of rat
Gordon, A. E., & Meldrum, B. S. (1970) · Biochemical Pharmacology · doi:10.1016/0006-2952(70)90091-2 · Cited by 37
Matzen, S., Secher, N. H., Knigge, U., Pawelczyk, J. A., Perko, G., Iversen, H. K., Bach, F. W., & Warberg, J. (1993) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1993.tb09609.x · Cited by 37
Effects of TAK-637, a Novel Neurokinin-1 Receptor Antagonist, on Colonic Function in Vivo
Okano, S., Nagaya, H., Ikeura, Y., Natsugari, H., & Inatomi, N. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29414-3 · Cited by 36
Estradiol or ovariectomy decreases crf synthesis in hypothalamus
Haas, D. A., & George, S. R. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90150-0 · Cited by 36
CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics
Kopin, A. S. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01526-1 · Cited by 36
CRH Effects on Central Noradrenergic Neurons: Relationship to Stress
Valentino, R. J. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_5 · Cited by 35
Saphier, D., Welch, J. E., Farrar, G. E., Nguyen, N. Q., Aguado, F., THALLER, T., & Knight, D. S. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90025-6 · Cited by 35
Characterization of [3H] CCK4 binding sites in mouse and rat brain
Durieux, C., Pélaprat, D., Charpentier, B., Morgat, J. L., & Roques, B. P. (1988) · Neuropeptides · doi:10.1016/0143-4179(88)90045-5 · Cited by 35
MILLER, M. A., Zoeller, R. T., & Dorsa, D. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90028-6 · Cited by 35
Holden, R. J., & Pakula, I. S. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0641 · Cited by 35
Imaki, J., Imaki, T., Vale, W., & Sawchenko, P. E. (1991) · Brain Research · doi:10.1016/0006-8993(91)90571-c · Cited by 35
Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain
Dorsa, D. M., Brot, M. D., Shewey, L. M., Meyers, K. M., Szot, P., & MILLER, M. A. (1988) · Synapse · doi:10.1002/syn.890020306 · Cited by 35
Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock
Qureshi, N. U., Dayao, E. K., Shirali, S., Żukowska-Grójec, Z., & Hauser, G. J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00071-8 · Cited by 34
Čulman, J., Wiegand, B., Spitznagel, H., Klee, S., & Unger, T. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13348.x · Cited by 34
Diurnal rhythm of plasma immunoreactive corticotropin-releasing factor in normal subjects
Watabe, T., TANAKA, K., Kumagae, M., Itoh, S., HASEGAWA, M., Horiuchi, T., Miyabe, S., Ohno, H., & Shimizu, N. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90013-0 · Cited by 34
Ceccatelli, S., Fahrenkrug, J., Villar, M. J., & Hökfelt, T. G. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90310-k · Cited by 34
SECRETION OF ACTH, LPH AND β‐ENDORPHIN FROM HUMAN PITUITARY TUMOURS IN VITRO
Gillies, G. E., Ratter, S. J., Grossman, A. B., Gaillard, R.-C., Lowry, P. J., BESSER, G. M., & REES, L. H. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb01042.x · Cited by 34
Nevo, I., Becker, C., Hamon, M., & Benoliel, J. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052041.x · Cited by 34
Acute rise in corticosterone facilitates 5-HT1A receptor-mediated behavioural responses
Meijer, O. C., Kortekaas, R., Oitzl, M. S., & de Kloet, E. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00289-1 · Cited by 34
MacKENZIE, C. J., Lutz, E. M., McCulloch, D., Mitchell, R., & Harmar, A. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17523.x · Cited by 34
Differential Effects of Three Acute Stressors on the Serotonin 5-HT 1A Receptor System in Rat Brain
Raghupathi, R. K., & McGonigle, P. (2008) · Neuroendocrinology · doi:10.1159/000127182 · Cited by 33
Heisler, L. E., Tumber, A. J., Rei, R. L., & Vugt, D. A. V. (2008) · Neuroendocrinology · doi:10.1159/000126762 · Cited by 33
Müller, M. B. (2000) · Endocrinology · doi:10.1210/en.141.11.4262 · Cited by 33
Fuxé, K., Agnati, L. F., VANDERHAEGHEN, J., Tatemoto, K., Andersson, K., Eneroth, P. H. E., Härfstrand, A., von Euler, G., Toni, R., Goldstein, M., et al. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb29921.x · Cited by 32
Jørgensen, H., Knigge, U., & Warberg, J. (2008) · Neuroendocrinology · doi:10.1159/000126251 · Cited by 32
The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones
Groenink, L., Mos, J., van der Gugten, J., & Olivier, B. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00088-3 · Cited by 32
Recent developments with neuropeptide Y receptor antagonists
Lundberg, J. M., Modin, A., & Malmström, R. E. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10032-8 · Cited by 32
Cholecystokinin peptides and receptors in the rat brain during stress
Harro, J., L�fberg, C., Rehfeld, J., & Oreland, L. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168707 · Cited by 32
Kjær, A., Knigge, U., Bach, F. W., & Warberg, J. (2008) · Neuroendocrinology · doi:10.1159/000126468 · Cited by 31
Substance P-Evoked release of GABA from isolated spinal cord of the newborn rat
Sakuma, M., Yoshioka, K., Suzuki, H., Yanagisawa, M., Onishi, Y., Kobayashi, N., & Otsuka, M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90229-h · Cited by 31
Lü, F., Yang, K., & Challis, J. R. G. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1430199 · Cited by 31
Armario, A., Martı́, O., Gavaldà, A., Giralt, M., & Jolín, T. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90015-d · Cited by 30
Kappa Opiate Receptors Inhibit Release of Oxytocin from the Magnocellular System during Dehydration
Summy‐Long, J. Y., Rosella-Dampman, L. M., McLemore, G. L., & Koehler, E. (2008) · Neuroendocrinology · doi:10.1159/000125364 · Cited by 30
Evaluation of linkage of markers on chromosome 6p with schizophrenia in Taiwanese families
Hwu, H., Lin, M., Lee, P.-C., Lee, S. F. ‐., Ouyang, W., & Liu, C. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1 · Cited by 30
Watanobe, H., Schiöth, H. B., Wikberg, J. E. S., & Suda, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02164-8 · Cited by 30
Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158
Tsutsumi, T., Akiyoshi, J., Isogawa, K., Kohno, Y., Hikichi, T., & Nagayama, H. (1999) · Neuropeptides · doi:10.1054/npep.1999.0766 · Cited by 30
VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas
Oliva, D., NICOSIA, S., Spada, A., & GIANNATTASIO, G. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90291-6 · Cited by 29
Central but not peripheral opiate receptor blockade prolonged pituitary-adrenal responses to stress
Odio, M. R., & Brodish, A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90386-v · Cited by 29
Dunn, A. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00064-3 · Cited by 29
Kim, D., Jung, J., Song, D.-K., Suh, H., Huh, S. O., & Kim, Y. (1998) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(97)00105-6 · Cited by 28
Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina
Oyamada, H., Takatsuji, K., Senba, E., Mantyh, P. W., & Tohyama, M. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00099-1 · Cited by 28
Bump, G. M., Reynolds, C. F., Smith, G. S., Pollock, B. G., Dew, M. A., Mazumdar, S., Geary, M., Houck, P. R., & Kupfer, D. J. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:3 · Cited by 28
Ray, A., Mediratta, P. K., Puri, S., & Sen, P. (1991) · PubMed · Cited by 28
Carter, D., Williams, T. D. M., & Lightman, S. L. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1110239 · Cited by 27
The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone
NICOSIA, S., Oliva, D., GIANNATTASIO, G., & Spada, A. (1983) · Journal of Endocrinological Investigation · doi:10.1007/bf03350614 · Cited by 27
Brain neuropeptide Y in the control of adrenocorticotropic hormone secretion in the dog
Inui, A., Inoue, T., Nakajima, M., Okita, M., Sakatani, N., Okimura, Y., Chihara, K., & Baba, S. (1990) · Brain Research · doi:10.1016/0006-8993(90)91369-r · Cited by 27
Distinguishing Multiple CCK Receptor Subtypes
Jensen, R. T., Qian, J., Lin, J., Mantey, S. A., Pisegna, J. R., & Wank, S. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44055.x · Cited by 27
Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses
Feldman, S., & Weidenfeld, J. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00052 · Cited by 26
CCK biosynthesis and processing: Recent progress and future challenges
Beinfeld, M. C. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00644-9 · Cited by 26
Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat
Matheson, G. K., Knowles, A., Guthrie, D., Gage, D., Weinzapfel, D., & Blackbourne, J. L. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00006-2 · Cited by 26
Yukhananov, R. Y., & Handa, R. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00432-0 · Cited by 26
Pralong, F. P., Corder, R., & Gaillard, R. C. (1993) · Neuropeptides · doi:10.1016/0143-4179(93)90107-l · Cited by 26
Saphier, D., & Welch, J. E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020767.x · Cited by 26
Schon, F., Allen, J. M., Yeats, J. C., Kent, A. S. H., Kelly, J. S., & Bloom, S. R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90138-7 · Cited by 25
CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic location
Hill, D. R., Shaw, T. M., Dourish, C. T., & Woodruff, G. N. (1988) · Brain Research · doi:10.1016/0006-8993(88)90807-4 · Cited by 25
Jørgensen, H., Kjær, A., Warberg, J., & Knigge, U. (2001) · Neuroendocrinology · doi:10.1159/000054649 · Cited by 25
de Kar, L. D. V., Urban, J. H., Lorens, S. A., & Richardson, K. D. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90231-0 · Cited by 25
Cholecystokinin Modulates Dopamine‐Mediated Behaviors
Crawley, J. N. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44060.x · Cited by 24
Carter, D., & Lightman, S. L. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90066-x · Cited by 24
Petrov, T., Jhamandas, J. H., & Krukoff, T. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90063-9 · Cited by 24
Golin, R., Gotoh, E., SAID, S., & Ganong, W. F. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90021-4 · Cited by 24
Neuropeptide Y inhibits corticosterone secretion by isolated rat adrenocortical cells
Malendowicz, L. K., Leśniewska, B., & Miśkowiak, B. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01939945 · Cited by 24
Defective regulation of vasopressin gene expression in Brattleboro rats
Majzoub, J. A., Carrazana, E. J., SHULMAN, J., Baker, K. J., & Emanuel, R. L. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e637 · Cited by 24
Elevated Neuropeptide Y Gene Expression and Release During Hypoglycemic Stress
Han, S., Chen, X., Wu, Y.-M., Naes, L., & Westfall, T. C. (1997) · Peptides · doi:10.1016/s0196-9781(97)00212-x · Cited by 23
Immunocytochemical identification of dynorphin-containing vesicles in brattleboro rats
Whitnall, M. H., Castel, M., Key, S., & Gainer, H. (1985) · Peptides · doi:10.1016/0196-9781(85)90047-6 · Cited by 23
de Kar, L. D. V., Lorens, S. A., Urban, J. H., Richardson, K. D., Paris, J. M., & Bethea, C. L. (1985) · Brain Research · doi:10.1016/0006-8993(85)91001-7 · Cited by 23
α2-adrenoceptor blockade, pituitary-adrenal hormones, and agonistic interactions in rats
Haller, J., Barna, I., & Kovács, J. L. (1994) · Psychopharmacology · doi:10.1007/bf02245571 · Cited by 22
Jessop, D. S., Chowdrey, H. S., & Lightman, S. L. (1990) · Neuropeptides · doi:10.1016/0143-4179(90)90076-b · Cited by 22
WESTENDORF, J. M., & Schönbrunn, A. (1985) · Endocrinology · doi:10.1210/endo-116-6-2528 · Cited by 22
Yagi, K., & Onaka, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12262-1 · Cited by 22
Characterization of high affinity binding sites for vasopressin in bovine adrenal medulla
Antoni, F. A. (1984) · Neuropeptides · doi:10.1016/0143-4179(84)90116-1 · Cited by 22
Hary, L., Dupouy, J., & Châtelain, A. (2008) · Neuroendocrinology · doi:10.1159/000123965 · Cited by 22
Becker, C. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00209-3 · Cited by 22
van Megen, H. J. G. M., Westenberg, H. G. M., & den Boer, J. A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00250-8 · Cited by 22
Krukoff, MacTavish, & Jhamandas, V. (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00391.x · Cited by 22
PACAP/VIP Receptor Subtypes, Signal Transducers, and Effectors in Pituitary Cellsa
Hezareh, M., Journot, L., Bresson‐Bepoldin, L., Schlegel, W., & Rawlings, S. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17493.x · Cited by 21
Juanéda, C., Dubourg, P., Ciofi, P., Sarrieau, A., Wenger, T., Tramu, G., & Corio, M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02365-4 · Cited by 21
Gaudreau, P., Quirion, R., St-Pierre, S. A., Chiueh, C. C., & Pert, A. (1987) · Neuropeptides · doi:10.1016/0143-4179(87)90003-5 · Cited by 21
Watanobe, H. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90028-u · Cited by 21
NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58
Keire, D. A., Solomon, T. E., & Reeve, J. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00309-1 · Cited by 21
Tsutsumi, T., Akiyoshi, J., Hikichi, T., Kiyota, A., Kohno, Y., Katsuragi, S., Yamamoto, Y., Isogawa, K., & Nagayama, H. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-18030 · Cited by 21
Giardino, L., Bettelli, C., Pozza, M., & Calzà, L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01242-1 · Cited by 20
Autoradiographic distribution of 125I-VIP binding in the rat adrenal cortex
Cunningham, L. A., & Holzwarth, M. A. (1989) · Peptides · doi:10.1016/0196-9781(89)90196-4 · Cited by 20
Footshock-induced changes in brain catecholamines and indoleamines are not mediated by CRF or ACTH
Dunn, A. J. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00163-1 · Cited by 20
Study of the Influence of Stress and Adrenalectomy on Central and Peripheral Neuropeptide Y Levels
Rivet, J., Castagné, V., Corder, R., Gaillard, R. C., & Mormède, P. (2008) · Neuroendocrinology · doi:10.1159/000125257 · Cited by 20
Li, Y., Wang, Z.-M., Zheng, H.-X., & Shi, J.-W. (1996) · Brain Research · doi:10.1016/0006-8993(96)00071-6 · Cited by 20
On the significance of cholecystokinin receptors in panic disorder
van Megen, H. J. G. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90090-6 · Cited by 20
Nakamura, H., Moroji, T., Nagase, H., Okazawa, T., & Okada, A. (1994) · European Journal of Applied Physiology · doi:10.1007/bf00599243 · Cited by 20
Akema, T., Chiba, A., Shinozaki, R., Oshida, M., Kimura, F., & Toyoda, J. (1996) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1996.tb00700.x · Cited by 20
Thorsell, A., Caberlotto, L., Rimondini, R., & Heilig, M. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00678-5 · Cited by 20
Blair, M. L., Woolf, P. D., & Felten, S. Y. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1197 · Cited by 20
Knigge, U., Matzen, S., Hannibal, T., Jørgensen, H., & Warberg, J. (2008) · Neuroendocrinology · doi:10.1159/000125974 · Cited by 19
Bockstaele, E. J. V. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00267-1 · Cited by 19
Neuroendocrine Functions of Histamine
Knigge, U., & Warberg, J. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7309-3_2 · Cited by 19
Kopin, A. S., Beinborn, M., Lee, Y. M., McBride, E. W., & Quinn, S. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44053.x · Cited by 18
The effect of acute and chronic administration of desmethylimipramine on responses to stress in rats
Stone, E. A., Trullás, R., & Platt, J. (1984) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(84)90019-8 · Cited by 18
Peptidergic pathways in the central nervous system
Mj, B. (1980) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1980.0120 · Cited by 17
Zhang, W., Lundberg, J. M., & Thorén, P. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007726626924 · Cited by 17
Brain distribution of vasoactive intestinal peptide receptors following REM sleep deprivation
Jiménez‐Anguiano, A., García‐García, F., Mendoza-Ramírez, J.-L., Durán-Vázquez, A., & Drucker-Colı́n, R. (1996) · Brain Research · doi:10.1016/0006-8993(96)00374-5 · Cited by 17
Brain Regulation of Renin Secretion Involves Central Histaminergic Neurons
Matzen, S., Knigge, U., & Warberg, J. (2008) · Neuroendocrinology · doi:10.1159/000125570 · Cited by 17
Léonard, J. F., Bluet‐Pajot, M., Oliver, C., & Kordon, C. (1988) · Neuropeptides · doi:10.1016/0143-4179(88)90043-1 · Cited by 17
Puybasset, L., Lacolley, P. J., Laurent, S., Mignon, F., Billaud, E. M., Cuche, J. L., Comoy, E., & Safar, M. E. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199306000-00010 · Cited by 17
Yagi, K., & Onaka, T. (1996) · Neuroscience Research · doi:10.1016/0168-0102(95)00988-4 · Cited by 17
Kovács, K., & Makara, G. B. (2008) · Neuroendocrinology · doi:10.1159/000126378 · Cited by 17
Asbach, S., Schulz, C., & Lehnert, H. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450359 · Cited by 17
Human brain levels of monoamines and their metabolites. Postmortem investigations.
GOTTFRIES, C. ‐. (1980) · PubMed · Cited by 17
HUMAN BRAIN LEVELS OF MONOAMINES AND THEIR METABOLITES. POSTMORTEM INVESTIGATIONS
Gottfries, C. G. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.1980.61.s280.49 · Cited by 17
5-HT Receptors Involved in the Regulation of Hormone Secretion
de Kar, L. D. V. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_20 · Cited by 16
Amiragova, M. G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90808-x · Cited by 16
Dual adrenergic control of renin during nonhypotensive hemorrhage in conscious dogs
Blair, M. L., Hisa, H., Sladek, C. D., Radke, K. J., & Gengo, F. M. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.6.e910 · Cited by 16
Methods in Neuroendocrinology.
Bohus, B. G. J. (1998) · Cited by 16
FOREBRAIN PATHWAYS MEDIATING STRESS‐INDUCED RENIN SECRETION
de Kar, L. D. V. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02591.x · Cited by 15
Morton, K. D. R., Johnson, M. D., & de Kar, L. D. V. (1995) · Brain Research · doi:10.1016/0006-8993(95)00891-s · Cited by 15
Keire, D. A., Solomon, T. E., & Reeve, J. R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1825 · Cited by 15
Feldman, S., Conforti, N., & Chowers, I. (1975) · European Journal of Endocrinology · doi:10.1530/acta.0.0800625 · Cited by 15
Bánki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90137-r · Cited by 15
Research works printed but not linked: 8
- Dahlstrom, 1965, Evidence for the existence of monoamine-containing neurons in the central nervous system IV, Acta Physiol. Scand., 64, 1
- Deak, 1999, The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 · DOI · Paper page
- Lorens, 1986, The serotonin antagonist LY53857, the 5-HT agonist 8-OH-DPAT, and intra-midbrain raphe, 5,7-dihidroxytryptamine lesions do not affect condiytioned fear induced increased in rennin secretion, Soc. Neurosci. Abstr., 12, 213
- Parsons, 1996, Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration, Behav. Brain Res., 73, 225, 10.1016/0166-4328(96)00101-5 · DOI
- Santarelli, 2001, Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function, Proc. Natl. Acad. Sc. U. S. A., 98, 1912, 10.1073/pnas.041596398 · DOI
- Van Megen, 1997, Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks, Psychopharmacology (Berl.), 129, 357, 10.1007/s002130050201 · DOI
- Wank, 1995, Chosystokinin receptors, Am. J. Physiol., 269, G628
- Zhang, 2001, Co-localization of 5-HT1A and 5-HT2A serotonin receptors on oxytocin cells in the hypothalamic paraventricular nucleus, Neurosci. Abstr., 17, 136
Cited by
Sorted by citations
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
The cortisol awakening response (CAR): Facts and future directions
Fries, E., Dettenborn, L., & Kirschbaum, C. (2009) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.03.014 · Cited by 1,188
The impact of stress on body function
Yaribeygi, H., Panahi, Y., Sahraei, H., Johnston, T. P., & Sahebkar, A. (2017) · EXCLI journal · doi:10.17179/excli2017-480 · Cited by 1,356
Metadata
- Authors
- Carrasco, G. A., & Van de Kar, L. D.
- Affiliations
- Loyola University Chicago (US)
- ORCID
- Carrasco, Gonzalo A
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 463
- Issue
- 1-3
- Pages
- 235-272
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1971277989
- Cited by
- 914
- References
- 656
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 37 · 2020: 32 · 2019: 30 · 2018: 36 · 2017: 27 · 2016: 36 · 2015: 34 · 2014: 43 · 2013: 64 · 2012: 49
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA013669, DA 13669)
- National Institute of Neurological Disorders and Stroke (NS34153)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- stress response, neuroendocrine regulation, corticotropin-releasing factor, vasopressin, renin-angiotensin system, hypothalamic-pituitary-adrenal axis, catecholamines, serotonin, substance P, vasoactive intestinal peptide, neuropeptide Y, cholecystokinin, benzodiazepines, anxiolytics, antidepressants, anxiety disorders, glucocorticoids, ACTH, sympathetic nervous system, adrenal medulla
- MeSH terms
- Amygdala, Animals, Brain Chemistry, Endocrine System, Humans, Hypothalamus, Neurosecretory Systems, Stress, Physiological, Neurotransmitter Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review